Novartis AG
Methods and compositions for treatment of cartilage damage and arthritis
Last updated:
Abstract:
The invention provides methods and compositions for the treatment of cartilage damage or arthritis by administration of a protease-resistant ANGPTL3 polypeptide with chondrogenic activity.
Status:
Grant
Type:
Utility
Filling date:
13 Nov 2017
Issue date:
7 Jun 2022